Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Linda J. Hong
The MEK1/2 Pathway as a Therapeutic Target in High-Grade Serous Ovarian Carcinoma
Related publications
GATA3 as a Master Regulator and Therapeutic Target in Ovarian High-Grade Serous Carcinoma Stem Cells
International Journal of Cancer
Cancer Research
Oncology
Retinoblastoma Pathway Deregulatory Mechanisms Determine Clinical Outcome in High-Grade Serous Ovarian Carcinoma
Modern Pathology
Forensic Medicine
Pathology
HMGA2: A Biomarker Significantly Overexpressed in High-Grade Ovarian Serous Carcinoma
Modern Pathology
Forensic Medicine
Pathology
Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Amplification of the Ch19p13.2 NACC1 Locus in Ovarian High-Grade Serous Carcinoma
Modern Pathology
Forensic Medicine
Pathology
Erratum To: Tubal Precursor Lesions in High Grade Serous Ovarian Carcinoma
Indian Journal of Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Molecular Abnormalities in Ovarian Cancer Subtypes Other Than High-Grade Serous Carcinoma
Journal of Oncology
Oncology
Characteristics of 10-Year Survivors of High-Grade Serous Ovarian Carcinoma
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Targeting IDH1 as a Pro-Senescent Therapy in High-Grade Serous Ovarian Cancer
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology